Safety and efficacy of daratumumab with ixazomib and dexamethasone in patients with one prior lenalidomide-based regimen: Outcomes of the phase 2 DARIA study

Authors
Category Primary study
JournalBlood
Year 2021
This article has no abstract
Epistemonikos ID: 38aec52bd3c30456830629f4b99c741f327c733c
First added on: Feb 13, 2025